Image (Rizatriptan 01)
Rizatriptan Benzoate Tablet
Product Images NDC 69097-866
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 69097-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Rizatriptan 02)
The text appears to be a table that includes percentages and medicine names, indicating the estimated probability of response for each. However, the has not provided clear information, making it difficult to understand the context and meaning of the information. Therefore, the description cannot be provided.*
Image (Rizatriptan 03)
This appears to be a chart displaying the "Estimated Probability of remedication or Rescue" for patients taking Placebo, Rizatriptan Benzoate Tablets 5mg and 10mg at different time points post-dose. The percentages range from 0%-100%, with some missing values.*
Image (Rizatriptan 04)
Image (Rizatriptan Benzoate 10mg Blister Foil)
This is a medication called Rizatriptan Benzoate Tablet with a strength of 10mg. The manufacturer is either Gipla USA, Inc or Cipla USA, Inc with a warning to keep out of reach of children. The product has a Lot number of 000000 and an expiration date of 00/0000, but the may have misinterpreted some of the characters making the information somewhat unclear.*
Image (Rizatriptan Benzoate 10mg Carton)
This is a medication label for Rizatriptan Benzoate tablets, USP by Cipla. It contains information about the dosage and dispensing of the medicine, including details such as the lot number and expiration date. A pharmacist is advised to dispense a patient information leaflet. The rest of the text is not readable.*
Image (Rizatriptan Benzoate 5mg Blister Foil)
This is a label for a medication called Rizatriptan Benzoate Tablet, USP. The tablets come in 5 mg dosage strength and are to be kept out of reach of children. The medication is manufactured by Cipla USA, Inc. The label also shows lot numbers and expiration dates. The medication is intended to be used for the treatment of certain types of migraine headaches.*
Image (Rizatriptan Benzoate 5mg Carton)
Rizatriptan Benzoate Tablets, USP is a prescription medicine provided in 18 unit-dose tablets. Each unit contains 6 tablets, and a patient information leaflet should be given to each patient. The NDC number is 69097-865-85 RxOnly. The remaining text seems to be a mix of unreadable characters and words, and it is therefore not possible to provide a useful and accurate description based on it.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
